A Randomized, Double-Blind, Placebo-Controlled, Phase I Study Of The Safety And Pharmacokinetics Of Two Doses Of Ct1812 In Subjects With Mild To Moderate Alzheimer’s Disease.
DEMENTIA TRIALS AUSTRALIA
A Randomized, Double-Blind, Placebo-Controlled, Phase I Study Of The Safety And Pharmacokinetics Of Two Doses Of Ct1812 In Subjects With Mild To Moderate Alzheimer’s Disease.